Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385514286> ?p ?o ?g. }
- W4385514286 endingPage "2848" @default.
- W4385514286 startingPage "2830" @default.
- W4385514286 abstract "Parkinson’s disease (PD) is characterized by dopaminergic neurodegeneration, resulting in dopamine depletion and motor behavior deficits. Since the discovery of L-DOPA, it has been the most prescribed drug for symptomatic relief in PD, whose prolonged use, however, causes undesirable motor fluctuations like dyskinesia and dystonia. Further, therapeutics targeting the pathological hallmarks of PD including α-synuclein aggregation, oxidative stress, neuroinflammation, and autophagy impairment have also been developed, yet PD treatment is a largely unmet success. The inception of the nanovesicle-based drug delivery approach over the past few decades brings add-on advantages to the therapeutic strategies for PD treatment in which nanovesicles (basically phospholipid-containing artificial structures) are used to load and deliver drugs to the target site of the body. The present review narrates the characteristic features of nanovesicles including their blood–brain barrier permeability and ability to reach dopaminergic neurons of the brain and finally discusses the current status of this technology in the treatment of PD. From the review, it becomes evident that with the assistance of nanovesicle technology, the therapeutic efficacy of anti-PD pharmaceuticals, phyto-compounds, as well as that of nucleic acids targeting α-synuclein aggregation gained a significant increment. Furthermore, owing to the multiple drug-carrying abilities of nanovesicles, combination therapy targeting multiple pathogenic events of PD has also found success in preclinical studies and will plausibly lead to effective treatment strategies in the near future." @default.
- W4385514286 created "2023-08-04" @default.
- W4385514286 creator A5020609438 @default.
- W4385514286 creator A5061122324 @default.
- W4385514286 creator A5073016286 @default.
- W4385514286 creator A5086534370 @default.
- W4385514286 date "2023-08-03" @default.
- W4385514286 modified "2023-09-27" @default.
- W4385514286 title "Combating Dopaminergic Neurodegeneration in Parkinson’s Disease through Nanovesicle Technology" @default.
- W4385514286 cites W1489218093 @default.
- W4385514286 cites W1498578881 @default.
- W4385514286 cites W1547461458 @default.
- W4385514286 cites W1565148871 @default.
- W4385514286 cites W1581439115 @default.
- W4385514286 cites W1584047372 @default.
- W4385514286 cites W1721689174 @default.
- W4385514286 cites W1843302206 @default.
- W4385514286 cites W1893133681 @default.
- W4385514286 cites W1918258073 @default.
- W4385514286 cites W1950590558 @default.
- W4385514286 cites W1964514091 @default.
- W4385514286 cites W1966053474 @default.
- W4385514286 cites W1968548319 @default.
- W4385514286 cites W1973114962 @default.
- W4385514286 cites W1974200504 @default.
- W4385514286 cites W1976799053 @default.
- W4385514286 cites W1982223225 @default.
- W4385514286 cites W1983398034 @default.
- W4385514286 cites W1984112300 @default.
- W4385514286 cites W1985735053 @default.
- W4385514286 cites W1986790622 @default.
- W4385514286 cites W1991128766 @default.
- W4385514286 cites W1996637092 @default.
- W4385514286 cites W1997091457 @default.
- W4385514286 cites W1998022180 @default.
- W4385514286 cites W1998388651 @default.
- W4385514286 cites W1999215303 @default.
- W4385514286 cites W1999815812 @default.
- W4385514286 cites W2002405028 @default.
- W4385514286 cites W2008323082 @default.
- W4385514286 cites W2011959160 @default.
- W4385514286 cites W2017026767 @default.
- W4385514286 cites W2023834592 @default.
- W4385514286 cites W2026884092 @default.
- W4385514286 cites W2027096397 @default.
- W4385514286 cites W2027822127 @default.
- W4385514286 cites W2028198856 @default.
- W4385514286 cites W2031509579 @default.
- W4385514286 cites W2033832481 @default.
- W4385514286 cites W2034161096 @default.
- W4385514286 cites W2035008654 @default.
- W4385514286 cites W2037500345 @default.
- W4385514286 cites W2038730603 @default.
- W4385514286 cites W2041546298 @default.
- W4385514286 cites W2041831342 @default.
- W4385514286 cites W2042391279 @default.
- W4385514286 cites W2043058890 @default.
- W4385514286 cites W2052098570 @default.
- W4385514286 cites W2053249930 @default.
- W4385514286 cites W2053969387 @default.
- W4385514286 cites W2059884588 @default.
- W4385514286 cites W2065180232 @default.
- W4385514286 cites W2069008440 @default.
- W4385514286 cites W2070336138 @default.
- W4385514286 cites W2073311838 @default.
- W4385514286 cites W2076743021 @default.
- W4385514286 cites W2077521565 @default.
- W4385514286 cites W2083475861 @default.
- W4385514286 cites W2087212218 @default.
- W4385514286 cites W2088198588 @default.
- W4385514286 cites W2090409342 @default.
- W4385514286 cites W2091250479 @default.
- W4385514286 cites W2092543733 @default.
- W4385514286 cites W2092968327 @default.
- W4385514286 cites W2095062003 @default.
- W4385514286 cites W2100898704 @default.
- W4385514286 cites W2101931293 @default.
- W4385514286 cites W2103738800 @default.
- W4385514286 cites W2106565509 @default.
- W4385514286 cites W2106983119 @default.
- W4385514286 cites W2109251309 @default.
- W4385514286 cites W2114042564 @default.
- W4385514286 cites W2125825438 @default.
- W4385514286 cites W2127866446 @default.
- W4385514286 cites W2129917259 @default.
- W4385514286 cites W2134786936 @default.
- W4385514286 cites W2137476611 @default.
- W4385514286 cites W2141976529 @default.
- W4385514286 cites W2143550648 @default.
- W4385514286 cites W2144217997 @default.
- W4385514286 cites W2149959669 @default.
- W4385514286 cites W2154761807 @default.
- W4385514286 cites W2160697936 @default.
- W4385514286 cites W2162391653 @default.
- W4385514286 cites W2170161076 @default.
- W4385514286 cites W2171373204 @default.
- W4385514286 cites W2171417336 @default.
- W4385514286 cites W2171471740 @default.